LEVACTAM levetiracetam 500mg film coated tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

levetiracetam, Quantity: 500 mg

Disponible desde:

Strides Pharma Science Pty Ltd

Designación común internacional (DCI):

Levetiracetam

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: colloidal anhydrous silica; povidone; magnesium stearate; hypromellose; iron oxide yellow; titanium dioxide; purified talc; crospovidone; macrogol 400

Vía de administración:

Oral

Unidades en paquete:

10 tablets, 100 tablets, 60 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Levetiracetam film-coated tablets are indicated for: ? use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation, ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME), and ? add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).

Resumen del producto:

Visual Identification: Yellow colour, oval shaped film coated tablets with break line on one side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-04-17